Kerafast Announces The University of Texas at Austin as 100th Providing Institution
Milestone reflects growing community of scientists offering bioreagents online
Boston, MASS., September 3, 2014. – Kerafast Inc., developers of an online platform to facilitate accessibility to bioresearch materials from laboratories across the globe, today announced an agreement with The University of Texas at Austin as Kerafast’s 100th Providing Institution. The University of Texas at Austin joins an ever-expanding assembly of academic institutions whose laboratory-derived research reagents are offered in Kerafast’s online catalog, streamlining access to difficult-to-obtain materials and advancing science by providing generous royalties back to the Providing investigators and their institutions.
“Kerafast is fostering a community of scientists giving back to science by promoting access to important rare and unique research materials that benefit both Providing and Procuring laboratories in their work towards the cure of disease,” said Robert Bondaryk, CEO. “We are extremely proud to have Dr. Andrew Ellington’s laboratory and The University of Texas at Austin as the 100th member of our program and to include the T7 polymerase variant from Dr. Ellington’s laboratory in our reagent portfolio.”
“At The University of Texas at Austin, we are committed to advancing research both at our institution and with external partners,” said Dan Sharp, Associate Vice President for Research and Director of the Office of Technology Commercialization. “The collaboration with Kerafast allows us to offer our reagents to the global scientific community, and to also realize an alternative funding source for the continuation of our research programs.”
As Kerafast’s 100th Provider, representatives from Dr. Ellington’s laboratory and The University of Texas at Austin will join members of the Kerafast team, Providers and Procurers as special guests at a community-wide celebration in Boston to mark this notable milestone.
About Kerafast, Inc.
Kerafast Inc., headquartered in Boston, Massachusetts, has created an online platform offering difficult-to-access bioresearch materials from prominent institutions around the world. Through a unique model, Kerafast supports a community of scientists advancing research by facilitating access to important bioreagents and providing generous royalties to contributing investigators and their institutions.
